(Q39494348)

12 September 2017

title

Serotonin 5-HT2A receptor-mediated hypertrophy is negatively regulated by caveolin-3 in cardiomyoblasts and neonatal cardiomyocytes (English)

1 reference

12 September 2017

0 references

1

Jeanne Mialet-Perez

1 reference

12 September 2017

Romina D'Angelo

2

1 reference

12 September 2017

Christelle Villeneuve

3

1 reference

12 September 2017

Catherine Ordener

4

1 reference

12 September 2017

Anne Nègre-Salvayre

5

1 reference

12 September 2017

Angelo Parini

6

1 reference

12 September 2017

Cécile Vindis

7

1 reference

12 September 2017

language of work or name

1 reference

28 July 2011

1 reference

Journal of Molecular and Cellular Cardiology

12 September 2017

published in

1 reference

12 September 2017

volume

52

1 reference

12 September 2017

issue

2

1 reference

12 September 2017

page(s)

502-510

1 reference

Serotonin responsiveness through 5-HT2A and 5-HT4 receptors is differentially regulated in hypertrophic and failing rat cardiac ventricle

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.07.019

Effects of serotonin in failing cardiac ventricle: signalling mechanisms and potential therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.07.019

Genetic deletion of MAO-A promotes serotonin-dependent ventricular hypertrophy by pressure overload

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.07.019

Dose-dependent activation of distinct hypertrophic pathways by serotonin in cardiac cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.07.019

Essential role of TRPC1 channels in cardiomyoblasts hypertrophy mediated by 5-HT2A serotonin receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.07.019

The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.07.019

The caveolae membrane system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.07.019

Caveolins, liquid-ordered domains, and signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.07.019

Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.07.019

The H9C2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.07.019

Activation of catalase by apelin prevents oxidative stress-linked cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.07.019

Unexpectedly strong binding of a large metal ion (Bi3+) to human serum transferrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.07.019

EphB1 recruits c-Src and p52Shc to activate MAPK/ERK and promote chemotaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.07.019

Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.07.019

A small molecular activator of cardiac hypertrophy uncovered in a chemical screen for modifiers of the calcineurin signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.07.019

Adenovirus-mediated overexpression of caveolin-3 inhibits rat cardiomyocyte hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.07.019

G-protein-coupled receptor signaling components localize in both sarcolemmal and intracellular caveolin-3-associated microdomains in adult cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.07.019

Caveolin-1 interacts with 5-HT2A serotonin receptors and profoundly modulates the signaling of selected Galphaq-coupled protein receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.07.019

G-protein coupled receptors in lipid rafts and caveolae: how, when and why do they go there?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.07.019

Cholesterol depletion inhibits epidermal growth factor receptor transactivation by angiotensin II in vascular smooth muscle cells: role of cholesterol-rich microdomains and focal adhesions in angiotensin II signaling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.07.019

Regulation of D1 dopamine receptor trafficking and signaling by caveolin-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.07.019

G protein- and agonist-bound serotonin 5-HT2A receptor model activated by steered molecular dynamics simulations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.07.019

Lipid rafts/caveolae as microdomains of calcium signaling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.07.019

Genetic evidence supporting caveolae microdomain regulation of calcium entry in endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.07.019

10.1016/J.YJMCC.2011.07.019

7 January 2021

Identifiers

DOI

1 reference

release_vmoavj2jnfch7a2nqgyarxjlri

12 September 2017

Fatcat ID

0 references

1 reference